Human Amyloidogenic Light Chains Directly Impair Cardiomyocyte Function Through an Increase in Cellular Oxidant Stress-Reference-Cited by-同舟云学术

Human Amyloidogenic Light Chains Directly Impair Cardiomyocyte Function Through an Increase in Cellular Oxidant Stress

Published:2004-04-30 Issue:8 Volume:94 Page:1008-1010
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circulation Research

Author:

Brenner Daniel A.¹,Jain Mohit¹,Pimentel David R.¹,Wang Bo¹,Connors Lawreen H.¹,Skinner Martha¹,Apstein Carl S.¹,Liao Ronglih¹

Affiliation:

1. From the Whitaker Cardiovascular Institute and Amyloid Treatment and Research Program, Evans Department of Medicine, Boston University School of Medicine, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference14 articles.

1. Molecular Mechanisms of Amyloidosis

2. Braunwald E. Heart Disease. 5th ed. Philadelphia Pa: W.B. Saunders Company; 1997.

3. Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only

4. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?;Clinical Research in Cardiology;2024-08-21

2. Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?;Expert Review of Hematology;2024-08-20

3. Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography;ESC Heart Failure;2024-08-11

4. Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis;JACC: Cardiovascular Imaging;2024-08

5. Systemic Diseases and Heart Block;Rheumatic Disease Clinics of North America;2024-08